Marta B.
- Country
- Spain
- Department
- Dermatology
Research Overview
- Evaluation of Lebrikizumab Efficacy and Safety in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Phase 3 Randomized Study
- A Phase 2b, Multicenter, Randomized, Double-blinded, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants with Moderate-to-Severe Atopic Dermatitis
Data & Insights
Has run more than one trial at 3 of 102 partner sites.
Specializations
Dermatological Research
This investigator specializes in the clinical evaluation of treatments for atopic dermatitis, with particular focus on advanced therapeutic approaches for moderate to severe cases.
- Chronic Skin Conditions
- Inflammatory Dermatoses
- Therapeutic Innovation
The research scope encompasses both adult and adolescent patient populations affected by dermatological conditions.
Immunological Focus
The investigator's work centers on immunological mechanisms in dermatological conditions, particularly exploring targeted therapeutic interventions for inflammatory skin disorders.
- Immune-Mediated Skin Diseases
- Biological Therapies
- Long-term Disease Management
Their research examines sustained clinical responses in chronic skin conditions through innovative treatment approaches.
Treatment Assessment
The investigator focuses on evaluating therapeutic effectiveness in dermatological conditions, with emphasis on long-term disease control and symptom management.
- Disease Severity Assessment
- Treatment Response Evaluation
- Clinical Outcomes Analysis
Their work includes comprehensive assessment of treatment efficacy across different dosing regimens and extended time periods.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.